Advanced wound care, distributed by reps inside the wound clinic.
Skin substitutes, amniotic biologics, advanced dressings — placed where the procedures happen.
Wound Care dynamics.
Wound care is rep-driven adoption with strong site-of-service economics. Buyers are wound clinics, podiatry practices, vascular surgery groups, and increasingly dermatology — each with their own protocols and procedural volume. Reimbursement context (LCDs, MAC coverage) shapes everything; site of service economics determine which products can be used where. The category rewards reps who understand both the clinical product fit and the billing reality.
Why this specialty fits Solara reps.
Solara wound care reps carry portfolios that align with how wound clinics actually buy — biologics alongside dressings and adjacent devices, with payer-aware talk tracks built in. Per-application economics are strong and procedural recurrence is durable: a converted physician applies the product weekly.
Apply to the networkWhat Solara delivers for wound care launches.
Manufacturers in wound care need reps who understand LCD coverage, MAC policies, and site-of-service economics for skin substitutes. Solara provides coverage across wound clinics and adjacent specialties with reps already conversant in those mechanics. Telemetry tracks application volume per physician and per site.
Book a working sessionWhat Wound Care reps see most.
- ·Diabetic foot ulcer
- ·Venous leg ulcer
- ·Pressure injury / decubitus ulcer
- ·Arterial ulcer
- ·Surgical wound dehiscence
- ·Burn wound (partial-thickness)
- ·Chronic non-healing wounds
Procedures that anchor the buying motion.
- 15275Application of skin substitute, ≤25 sq cm
- 97597Selective debridement, ≤20 sq cm
- 11042Debridement of subcutaneous tissue
- 15271Application of skin substitute, lower extremity
- 97605Negative pressure wound therapy
Product categories most relevant to wound care.
Common questions about wound care on Solara.
- Are Solara wound care reps fluent in LCD and MAC coverage?
Yes. Wound care reps are trained on the relevant LCDs for skin substitutes, debridement, and NPWT, and on payer-side coverage variation by MAC region. Manufacturer-specific evidence dossiers and coverage tools are part of the rep enablement workflow.
- Does Solara cover both wound clinics and physician offices?
Yes. Coverage extends to wound clinics, podiatry offices, vascular surgery practices, dermatology offices, and dedicated wound care programs in outpatient settings. Reimbursement context differs across these settings and reps are trained accordingly.
- How does Solara handle the compliance complexity around skin substitutes?
Reps follow manufacturer-approved promotional materials only, with compliance review built into the script and territory enablement workflow. Audit-logged activity, on-label messaging discipline, and documented training are platform primitives.
- What does Solara's targeting look like for wound care?
Site-level application volume by CPT, physician specialty mix, payer mix (Medicare-heavy panels weight higher for skin substitutes), and historical product mix where reportable. ICP scoring surfaces the practices most likely to adopt your specific product and indication.
See your wound care territory.
Drop in your metro on the territory preview tool — we'll surface the top 50 physicians most likely to adopt your product, scored on five signals.